4//SEC Filing
RAKIN KEVIN 4
Accession 0001213900-22-008755
CIK 0001176309other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:30 PM ET
Size
8.6 KB
Accession
0001213900-22-008755
Insider Transaction Report
Form 4
RAKIN KEVIN
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-02-17−6,667→ 0 totalExercise: $4.80From: 2020-12-30Exp: 2030-01-08→ Common Stock (6,667 underlying) - Tax Payment
Common Stock
2022-02-17$10.63/sh−3,010$31,996→ 56,661 total - Exercise/Conversion
Common Stock
2022-02-17$4.80/sh+6,667$32,002→ 59,671 total
Footnotes (1)
- [F1]Represents a cashless exercise of outstanding stock options to purchase 6,667 shares of common stock. The reporting person received 3,657 shares of common stock and surrendered 3,010 shares of common stock underlying the stock option in payment of the exercise price.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001184421
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:30 PM ET
- Size
- 8.6 KB